Figure 1.
Arithmetic mean (SD) midazolam plasma pharmacokinetic concentration (concn)‐time profiles after administration of midazolam 5 mg at baseline (before secukinumab administration) and at day 8, and at day 36 during secukinumab treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.